The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease

Cellular Physiology and Biochemistry

Volumn 46, Issue 6, 2018, Pages 2624-2635

  Tang, Bo ^a,b   Li, Xue ^a   Liu, Yuanlin ^a   Chen, Xiuhui ^a   Li, Ximei ^a   Chu, Yanan ^a   Zhu, Heng ^a   Liu, Weijiang ^a,d   Xu, Fenfen ^a   Zhou, Fan ^c   Zhang, Yi ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow transplantation; Graft versus host disease; Intercellular adhesion molecule 1; Mesenchymal stem cells; Murine GVHD model

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE TRANSFORMATION; LYMPHOID TISSUE; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SECONDARY LYMPHOID ORGAN; SURVIVAL; T LYMPHOCYTE; TH1 CELL; ANIMAL; C57BL MOUSE; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; IMMUNOTHERAPY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; UPREGULATION;

ANIMALS; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; GRAFT VS HOST DISEASE; IMMUNOTHERAPY; INTERCELLULAR ADHESION MOLECULE-1; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; UP-REGULATION;

EID: 85047143825     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000489689     Document Type: Article

References (44)

1. Johnston L: Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity. Best Pract Res Clin Haematol 2008;21:177-192.
2. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, Shlomchik MJ, Emerson SG: Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412-415.
3. Anderson BE, McNiff JM, Jain D, Blazar BR, Shlomchik WD, Shlomchik MJ: Distinct roles for donor-and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005;105:2227-2234.
4. Matte CC, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D, McNiff J, Shlomchik WD: Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004;10:987-992.
5. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822.
6. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
7. Hashmi S, Ahmed M, Murad MH, Litzow MR, Adams RH, Ball LM, Prasad VK, Kebriaei P, Ringden O: Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. Lancet Haematol 2016;3: 45-52.
8. Sudres M, Norol F, Trenado A, Gregoire S, Charlotte F, Levacher B, Lataillade JJ, Bourin P, Holy X, Vernant JP, Klatzmann D, Cohen JL: Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006;176:7761-7767.
9. Tolar J, Le Blanc K, Keating A, Blazar BR: Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 2010;28:1446-1455.
10. Kebriaei P, Robinson S: Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy 2011;13:262-268.
11. Kang SK, Shin IS, Ko MS, Jo JY, Ra JC: Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int 2012;2012:342968.
12. Karp JM, Leng Teo GS: Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009;4:206-216.
13. Pribila JT, Quale AC, Mueller KL, Shimizu Y: Integrins and T cell-mediated immunity. Annu Rev Immunol 2004;22:157-180.
14. Isobe M, Suzuki J, Yamazaki S, Yazaki Y, Horie S, Okubo Y, Maemura K, Yazaki Y, Sekiguchi M: Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation 1997;96:2247-2253.
15. Sumagin R, Brazil JC, Nava P, Nishio H, Alam A, Luissint AC, Weber DA, Neish AS, Nusrat A, Parkos CA: Neutrophil interactions with epithelial-expressed ICAM-1 enhances intestinal mucosal wound healing. Mucosal Immunol 2016;9:1151-1162.
16. Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G: How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 2012;33:136-143.
17. Ren G, Roberts AI, Shi Y: Adhesion molecules: key players in Mesenchymal stem cell-mediated immunosuppression. Cell Adh Migr 2011;5:20-22.
18. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, Ling W, Roberts AI, Le AD, Shi S, Shao C, Shi Y: Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010;184:2321-2328.
19. Xu FF, Zhu H, Li XM, Yang F, Chen JD, Tang B, Sun HG, Chu YN, Zheng RX, Liu YL, Wang LS, Zhang Y: Intercellular adhesion molecule-1 inhibits osteogenic differentiation of mesenchymal stem cells and impairs bio-scaffold-mediated bone regeneration in vivo. Tissue Eng Part A 2014;20:2768-2782.
20. Kaplan DH, Anderson BE, McNiff JM, Jain D, Shlomchik MJ, Shlomchik WD: Target antigens determine graft-versus-host disease phenotype. J Immunol 2004;173:5467-5475.
21. Mellman I, Steinman RM: Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106:255-258.
22. Piccirillo CA, Shevach EM: Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 2004;16:81-88.
23. Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J Jr, Ferrara JL: Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998;102:1882-1891.
24. Leveson-Gower DB, Olson JA, Sega EI, Luong RH, Baker J, Zeiser R, Negrin RS: Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. Blood 2011;117:3220-3229.
25. Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, Genrich K, Mehrotra S, Setty S, Smith B, Bartholomew A: IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 2008;38:1745-1755
26. Qiao SK, Ren HY, Shi YJ, Liu W: Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates the Severity of Idiopathic Pneumonia Syndrome in a Murine Bone Marrow Transplantation Model. Cell Physiol Biochem 2016;40:1656-1669.
27. Sudres M, Norol F, Trenado A, Gregoire S, Charlotte F, Levacher B, Lataillade JJ, Bourin P, Holy X, Vernant JP, Klatzmann D, Cohen JL: Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006;176:7761-7767.
28. Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE: Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 2012;18:456-462.
29. Liu HB, Liu SB, Li Y, Wang XH, Xue WJ, Ge GQ, Luo XH: The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury. PloS One 2012;7: e34608.
30. Yang DZ, Sun SJ, Wang ZG, Zhu PF, Yang ZL, Zhang B: Stromal Cell-Derived Factor-1 Receptor CXCR4-Overexpressing Bone Marrow Mesenchymal Stem Cells Accelerate Wound Healing by Migrating into Skin Injury Areas. Cell Reprogram 2013;15:206-215.
31. Li H, Jiang Y, Jiang X, Guo X, Ning H, Li Y, Liao L, Yao H, Wang X, Liu Y, Zhang Y, Chen H, Mao N: CCR7 Guides Migration of Mesenchymal Stem Cell to Secondary Lymphoid Organs: A Novel Approach to Separate GvHD from GvL Effect. Stem Cells 2014;32:1890-1903.
32. Stoll S, Delon J, Brotz TM, Germain RN: Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 2002;296:1873-1876.
33. Malhotra D, Fletcher AL, Turley SJ: Stromal and hematopoietic cells in secondary lymphoid organs: partners in immunity. Immunol Rev 2013;251:160-176.
34. Miller MJ, Wei SH, Parker I, Cahalan MD: Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002;296:1869-1873.
35. Mempel TR, Henrickson SE, von Andrian UH: T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 2004;427:154-159.
36. Gassa A, Kalkavan H, Jian F, Duhan V, Khairnar V, Shaabani N, Honke N, Carpinteiro A, Botezatu L, Crivello P, Dolff S, Ferencik S, Häussinger D: High Frequencies of Anti-Host Reactive CD8(+) T Cells Ignore Non-Hematopoietic Antigen after Bone Marrow Transplantation in a Murine Model. Cell Physiol Biochem 2016;38:1343-1353.
37. Nestel FP, Price KS, Seemayer TA, Lapp WS: Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 1992;175:405-413.
38. Lu Y, Waller EK: Dichotomous role of interferon-gamma in allogeneic bone marrow transplant. Biol Blood Marrow Transplant 2009;15:1347-1353.
39. Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S, Utsugi T, Verdaguer J, Santamaria P: CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity 2003;19:877-889.
40. Janssens W, Carlier V, Wu B, VanderElst L, Jacquemin MG, Saint-Remy JM: CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol 2003;171:4604-4612.
41. Buckner JH: Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010;10:849-859.
42. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003;101:3722-3729.
43. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM: Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002;99:3838-3843.
44. Li H, Guo Z, Jiang X, Zhu H, Li X, Mao N: Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 2008;26:2531-2541.